AdaptHealth Corp. (AHCO)
AdaptHealth Corp. (AHCO)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Change in fair value of warrant liability | NaN | 0 | 0 | 0 |
| Net loss | -14,873 | -101,537 | 25,750 | 9,749 |
| Depreciation and amortization, including patient equipment depreciation | 106,469 | 97,506 | 97,716 | 186,705 |
| Loss on extinguishment of debt | NaN | 0 | 0 | NaN |
| Change in fair value of interest rate swaps, net of reclassification adjustment | NaN | 0 | 0 | 0 |
| Goodwill impairment | NaN | 127,995 | 0 | 0 |
| Payment of contingent consideration from an acquisition | NaN | 0 | 0 | 0 |
| Equity-based compensation | 6,532 | 5,138 | 5,311 | 11,427 |
| Gain on sale of businesses (note 4) | NaN | 377 | 0 | 32,225 |
| Reduction in the carrying amount of operating lease right-of-use assets | 10,659 | 8,168 | 7,646 | 15,300 |
| Reduction in the carrying amount of finance lease right-of-use assets | 5,046 | 4,400 | 3,846 | 7,096 |
| Deferred income tax benefit | -5,600 | -4 | 34,524 | 12,643 |
| Amortization of deferred financing costs | 1,186 | 1,257 | 1,332 | 3,105 |
| Writeoff of fixed assets | 691 | NaN | NaN | NaN |
| Other | -786 | -5,721 | 3,000 | NaN |
| Accounts receivable | 21,069 | -8,844 | -13,274 | -8,868 |
| Inventory | 7,751 | 1,742 | 36 | 9,713 |
| Prepaid and other assets | -11,913 | -13,988 | 70,481 | 4,578 |
| Operating lease obligations | -10,298 | -7,643 | -7,662 | -15,812 |
| Operating liabilities | 11,603 | 27,470 | 46,846 | 64,956 |
| Net cash provided by operating activities | 93,722 | 183,184 | 161,066 | 257,521 |
| Proceeds from the sale of businesses, net of cash disposed | NaN | 3,245 | 1,501 | 115,674 |
| Purchases of equipment and other fixed assets | 121,212 | 103,896 | 94,242 | 184,250 |
| Payments for business acquisitions | 84,683 | 23,817 | 0 | 18,561 |
| Proceeds from the sale of assets | 1,439 | 0 | 0 | NaN |
| Payments for cost method investments | NaN | 0 | NaN | NaN |
| Receipt of contingent consideration from the sale of assets | NaN | 0 | 0 | 1,156 |
| Net cash used in investing activities | -204,456 | -124,468 | -92,741 | -85,981 |
| Proceeds from borrowings on lines of credit | 100,000 | 0 | 0 | 0 |
| Repayments on long-term debt and lines of credit | 14,063 | 25,000 | 50,000 | 175,000 |
| Repayments of finance lease obligations | 3,104 | 6,299 | 3,833 | 8,346 |
| Payments for shares purchased under share repurchase program | NaN | 0 | NaN | NaN |
| Proceeds from the exercise of stock options | NaN | 0 | 0 | 0 |
| Proceeds received in connection with employee stock purchase plan | 464 | 1 | 646 | 564 |
| Payments relating to the tax receivable agreement | 26,846 | 0 | 33 | 25,012 |
| Payments of debt financing costs | NaN | 0 | 0 | NaN |
| Distributions to noncontrolling interests | 1,522 | 1,541 | 2,853 | 2,573 |
| Payments for tax withholdings from vesting of restricted stock units | 2,367 | 97 | 525 | 2,079 |
| Payments of contingent consideration and deferred purchase price from acquisitions | NaN | 1 | 0 | 211 |
| Net cash provided by (used in) financing activities | 52,562 | -32,937 | -56,598 | -212,657 |
| Net decrease in cash | -58,172 | 25,779 | 11,727 | -41,117 |
| Cash at beginning of period | 106,136 | 80,357 | 109,747 | NaN |
| Cash at end of period | 47,964 | 106,136 | 80,357 | NaN |